Veterinary Medicines

Lovatrim LA (200 mg + 40 mg)/ml Roztwór do wstrzykiwań

Authorised
  • Sulfadoxine
  • Trimethoprim
Download as PDF

Product identification

Medicine name:
Lovatrim LA (200 mg + 40 mg)/ml Roztwór do wstrzykiwań
Active substance:
  • Sulfadoxine
  • Trimethoprim
Target species:
  • Cattle
  • Pig
  • Horse
  • Sheep
Route of administration:
  • Subcutaneous use
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Sulfadoxine
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Trimethoprim
    40.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        9
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        8
        day
    • Horse
      • Meat and offal
        10
        day
    • Sheep
      • Milk
        108
        hour
      • Meat and offal
        14
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        9
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        8
        day
    • Horse
      • Meat and offal
        10
        day
    • Sheep
      • Milk
        108
        hour
      • Meat and offal
        14
        day
  • Intramuscular use
    • Cattle
      • Milk
        72
        hour
      • Meat and offal
        9
        day
    • Pig
      • Meat and offal
        8
        day
    • Horse
      • Meat and offal
        10
        day
    • Sheep
      • Milk
        108
        hour
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01EW13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Lovapharm Consulting B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Interchemie Werken De Adelaar Eesti AS
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 3401
Date of authorisation status change:
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 9/02/2026
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 9/02/2026
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 9/02/2026
Download